In adults with overweight or obesity (without diabetes) the semaglutide 2.4 mg dose produced an average weight reduction of about 15% of baseline body weight over ~68 weeks in the STEP 1 trial, a result that surprised many clinicians because it brought pharmacologic outcomes into a range previously associated with surgical interventions
Improves absorption and bioavailability
(The cholesterol lowering medication called statins-lower Co-Q 10 levels which impair mitochondria function), Blood pressure medications like the Beta Blockers, tricyclic antidepressants, muscle relaxants and may others
sharp needles present a serious injury risk if handled by untrained individuals
Support the Gut Microbiome A diverse and healthy microbiome is essential for motility
Gossard, DCN, CNS, LDN, indeed, ashwagandha and L-theanine have a lot of (wonderful) things in common